Salarius Pharmaceuticals Rebrands as Decoy Therapeutics and Changes Nasdaq Ticker to DCOY
Salarius Pharmaceuticals announced it will change its corporate name to Decoy Therapeutics Inc. and begin trading on the Nasdaq Capital Market under the new ticker symbol DCOY starting January 8, 2026, to reflect its strategic focus on developing next-generation peptide-conjugate therapeutics. The rebranding underscores the company’s commitment to advancing its AI-enabled platform and lead antiviral and oncology programs while maintaining corporate continuity and operational leadership.
Salarius Pharmaceuticals Rebrands as Decoy Therapeutics and Changes Nasdaq Ticker to DCOY